Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1151

1.

Percutaneous radiofrequency ablation for early hepatocellular carcinoma: risk factors for survival.

Kikuchi L, Menezes M, Chagas AL, Tani CM, Alencar RS, Diniz MA, Alves VA, D'Albuquerque LA, Carrilho FJ.

World J Gastroenterol. 2014 Feb 14;20(6):1585-93. doi: 10.3748/wjg.v20.i6.1585.

2.

[Efficacy of radiofrequency ablation to treat advanced hepatocellular carcinoma].

Wu J, Chen MH, Yang W, Wu W, Yan K.

Zhonghua Gan Zang Bing Za Zhi. 2012 Apr;20(4):256-60. doi: 10.3760/cma.j.issn.1007-3418.2012.04.006. Chinese.

PMID:
22964144
3.

Initial treatment response is essential to improve survival in patients with hepatocellular carcinoma who underwent curative radiofrequency ablation therapy.

Takahashi S, Kudo M, Chung H, Inoue T, Ishikawa E, Kitai S, Tatsumi C, Ueda T, Minami Y, Ueshima K, Haji S.

Oncology. 2007;72 Suppl 1:98-103. Epub 2007 Dec 13.

PMID:
18087189
4.

[Long term (5 years) outcome of radiofrequency ablation for hepatocellular carcinoma in 256 cases].

Chen MH, Yan K, Yang W, Gao W, Dai Y, Huo L, Zhang H, Huang XF.

Beijing Da Xue Xue Bao. 2005 Dec 18;37(6):671-2. Chinese.

5.

Percutaneous radiofrequency ablation as first-line treatment for small hepatocellular carcinoma: results and prognostic factors on long-term follow up.

Waki K, Aikata H, Katamura Y, Kawaoka T, Takaki S, Hiramatsu A, Takahashi S, Toyota N, Ito K, Chayama K.

J Gastroenterol Hepatol. 2010 Mar;25(3):597-604. doi: 10.1111/j.1440-1746.2009.06125.x. Epub 2010 Jan 14.

PMID:
20074153
6.

Radiofrequency ablation of hepatocellular carcinoma in difficult locations: Strategies and long-term outcomes.

Yang W, Yan K, Wu GX, Wu W, Fu Y, Lee JC, Zhang ZY, Wang S, Chen MH.

World J Gastroenterol. 2015 Feb 7;21(5):1554-66. doi: 10.3748/wjg.v21.i5.1554.

7.

Role of surgical resection for multiple hepatocellular carcinomas.

Choi SH, Choi GH, Kim SU, Park JY, Joo DJ, Ju MK, Kim MS, Choi JS, Han KH, Kim SI.

World J Gastroenterol. 2013 Jan 21;19(3):366-74. doi: 10.3748/wjg.v19.i3.366.

8.

[Effect and prognostic analysis of radiofrequency ablation in treating advanced hepatocellular carcinoma].

Wu J, Chen MH, Yan K, Wu W, Yang W.

Zhonghua Yi Xue Za Zhi. 2012 Mar 20;92(11):735-8. Chinese.

PMID:
22781351
9.

Radiofrequency ablation of hepatocellular carcinoma as first-line treatment: long-term results and prognostic factors in 162 patients with cirrhosis.

Lee DH, Lee JM, Lee JY, Kim SH, Yoon JH, Kim YJ, Han JK, Choi BI.

Radiology. 2014 Mar;270(3):900-9. doi: 10.1148/radiol.13130940. Epub 2013 Oct 30.

PMID:
24475823
10.

Ten-year survival of hepatocellular carcinoma patients undergoing radiofrequency ablation as a first-line treatment.

Yang W, Yan K, Goldberg SN, Ahmed M, Lee JC, Wu W, Zhang ZY, Wang S, Chen MH.

World J Gastroenterol. 2016 Mar 14;22(10):2993-3005. doi: 10.3748/wjg.v22.i10.2993.

11.

Radiofrequency ablation for intrahepatic recurrent hepatocellular carcinoma: long-term results and prognostic factors in 168 patients with cirrhosis.

Lee DH, Lee JM, Lee JY, Kim SH, Han JK, Choi BI.

Cardiovasc Intervent Radiol. 2014 Jun;37(3):705-15. doi: 10.1007/s00270-013-0708-x. Epub 2013 Aug 3.

PMID:
23912493
12.

Intrahepatic distant recurrence following complete radiofrequency ablation of small hepatocellular carcinoma: risk factors and early MRI evaluation.

Sheng RF, Zeng MS, Ren ZG, Ye SL, Zhang L, Chen CZ.

Hepatobiliary Pancreat Dis Int. 2015 Dec;14(6):603-12.

13.

Single hepatocellular carcinoma ≤ 3 cm in left lateral segment: liver resection or radiofrequency ablation?

Kim JM, Kang TW, Kwon CH, Joh JW, Ko JS, Park JB, Rhim H, Lee JH, Kim SJ, Paik SW.

World J Gastroenterol. 2014 Apr 14;20(14):4059-65. doi: 10.3748/wjg.v20.i14.4059.

14.

[The factors related to the prognosis of solitary hepatocellular carcinoma after radiofrequency ablation].

Chung IK, Park MJ, Kwon KT, Park YD, Chung YJ, Jeon SW, Lee MK, Seo HE, Lee YD, Cho CM, Tak WY, Kweon YO, Kim SK, Choi YH.

Korean J Hepatol. 2005 Dec;11(4):371-80. Korean.

15.

Risk factors of survival after percutaneous radiofrequency ablation of hepatocellular carcinoma.

Peng ZW, Zhang YJ, Chen MS, Liang HH, Li JQ, Zhang YQ, Lau WY.

Surg Oncol. 2008 Jul;17(1):23-31. Epub 2007 Sep 14.

PMID:
17869095
16.

Percutaneous radiofrequency thermal ablation of hepatocellular carcinoma: a safe and effective bridge to liver transplantation.

Fontana RJ, Hamidullah H, Nghiem H, Greenson JK, Hussain H, Marrero J, Rudich S, McClure LA, Arenas J.

Liver Transpl. 2002 Dec;8(12):1165-74.

17.

Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome.

Zytoon AA, Ishii H, Murakami K, El-Kholy MR, Furuse J, El-Dorry A, El-Malah A.

Jpn J Clin Oncol. 2007 Sep;37(9):658-72. Epub 2007 Aug 31.

PMID:
17766723
18.

Radiofrequency ablation of hepatocellular carcinoma: long-term results and prognostic factors in 235 Western patients with cirrhosis.

N'Kontchou G, Mahamoudi A, Aout M, Ganne-Carrié N, Grando V, Coderc E, Vicaut E, Trinchet JC, Sellier N, Beaugrand M, Seror O.

Hepatology. 2009 Nov;50(5):1475-83. doi: 10.1002/hep.23181.

PMID:
19731239
19.

Risk factors for exceeding the Milan criteria after successful radiofrequency ablation in patients with early-stage hepatocellular carcinoma.

Tsuchiya K, Asahina Y, Tamaki N, Yasui Y, Hosokawa T, Ueda K, Nakanishi H, Itakura J, Kurosaki M, Enomoto N, Izumi N.

Liver Transpl. 2014 Mar;20(3):291-7.

PMID:
24734314
20.

Analysis of recurrence pattern and its influence on survival outcome after radiofrequency ablation of hepatocellular carcinoma.

Ng KK, Poon RT, Lo CM, Yuen J, Tso WK, Fan ST.

J Gastrointest Surg. 2008 Jan;12(1):183-91. Epub 2007 Sep 15.

PMID:
17874276

Supplemental Content

Support Center